A mass peak at m/z 4972.1, identified as thymosin beta‑4, was highly over-represented in secretions of the Epstein-Barr virus transformed B-cell line compared with normal B-cells.
In plain wordsCells transformed by Epstein-Barr virus released more of their own thymosin beta‑4 than normal B-cells did.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- IncreaseSecretion of thymosin beta-4 by transformed versus normal B-cells
- Study
humann: not reported in source
Normal B-cells and Epstein-Barr virus transformed B-cell line (LCL)- Comparator
- Normal B-cells
- Outcome group
- Tumor growth · Cancer
Measurements
- Mass peak
- 4972.1 m/z
- transformed B-cell line
Source sentences
A mass peak at m/z = 4972.1 that was highly over-represented in the transformed B-cell line was chosen for identification and purified by reversed phase chromatography with concomitant monitoring of fractions by SELDI-TOF MS.
2 context sentences(design, population, supporting numbers)
Fragment matching of the resulting peptides identified the protein as thymosin beta-4.
Mass spectra of the range of proteins secreted from normal B-cells were generated along with those secreted from Epstein-Barr virus transformed B-cells.
This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.